v3.25.1
Consolidated Statements of Operations - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Income Statement [Abstract]      
Revenues $ 658
Cost of revenues 1,238
Gross loss 580
Research and development expenses, net 5,532 5,210 5,765
Marketing, general and administrative expenses 2,526 4,505 5,296
Other income (9)
Total operating expenses 8,058 9,706 11,061
Total operating loss 8,638 9,706 11,061
Gain on troubled debt restructuring (14,759)
Financial expenses (income) net, 1,325 (3,206) (5,265)
Net loss (Income) $ (4,796) $ 6,500 $ 5,796
Net loss (Income) per ordinary share attributable to shareholders, basic (in Dollars per share) $ 0.004 $ 0.01
Net loss (Income) per ordinary share attributable to shareholders, diluted (in Dollars per share) $ 0.004 $ 0.01
Weighted average number of shares used in computing net loss (income) per share attributable to ordinary shareholders, basic (in Shares) 3,225,472,266 1,562,627,495 754,076,407
Weighted average number of shares used in computing net loss (income) per share attributable to ordinary shareholders, diluted (in Shares) 3,225,472,266 1,562,627,495 754,076,407